| Child and Adolescent Health | Lifetime | 265 | US 132 | 97.23 |
| Pharmaceutical Practices and Patient Outcomes | Lifetime | 308 | US 124 | 97.43 |
| Health and Medical Research Impacts | Lifetime | 154 | US 84 | 95.98 |
| Biomedical Ethics and Regulation | Lifetime | 134 | US 79 | 95.89 |
| Pharmaceutical studies and practices | Lifetime | 413 | US 201 | 97.04 |
| Opioid Use Disorder Treatment | Lifetime | 293 | US 212 | 97.05 |
| Pharmaceutical industry and healthcare | Lifetime | 96 | US 63 | 96.08 |
| Social Media in Health Education | Lifetime | 120 | US 68 | 95.66 |
| Pharmaceutical Economics and Policy | Lifetime | 326 | US 159 | 95.85 |
| Science, Research, and Medicine | Lifetime | 47 | US 21 | 95.80 |
| Economic and Financial Impacts of Cancer | Lifetime | 465 | US 300 | 95.34 |
| Antibiotic Use and Resistance | Lifetime | 698 | US 235 | 96.06 |
| Vaccine Coverage and Hesitancy | Lifetime | 914 | US 418 | 95.12 |
| Adolescent and Pediatric Healthcare | Lifetime | 680 | US 351 | 94.86 |
| Ethics and Legal Issues in Pediatric Healthcare | Lifetime | 443 | US 232 | 92.28 |
| Poisoning and overdose treatments | Lifetime | 555 | US 282 | 92.46 |
| Biotechnology and Related Fields | Lifetime | 237 | US 111 | 89.90 |
| Pharmacology and Obesity Treatment | Lifetime | 977 | US 411 | 90.79 |
| Public Health Policies and Education | Lifetime | 508 | US 341 | 88.47 |
| Health Sciences Research and Education | Lifetime | 957 | US 433 | 88.25 |
| Genetics, Bioinformatics, and Biomedical Research | Lifetime | 832 | US 460 | 84.92 |
| Gun Ownership and Violence Research | Lifetime | 363 | US 311 | 88.07 |
| Intramuscular injections and effects | Lifetime | 234 | US 91 | 84.01 |
| Health and Conflict Studies | Lifetime | 591 | US 236 | 82.28 |
| Veterinary Practice and Education Studies | Lifetime | 450 | US 159 | 80.49 |
| Healthcare Systems and Challenges | Lifetime | 362 | US 55 | 78.10 |
| Sex and Gender in Healthcare | Lifetime | 538 | US 294 | 77.97 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 905 | US 269 | 70.89 |
| Safe Handling of Antineoplastic Drugs | Lifetime | 530 | US 169 | 69.35 |
| Pharmaceutical Quality and Counterfeiting | Lifetime | 496 | US 104 | 62.32 |
| Healthcare Policy and Management | 2021-2025 | 214 | US 168 | 93.29 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 572 | US 197 | 93.20 |
| Poxvirus research and outbreaks | 2021-2025 | 160 | US 35 | 88.61 |
| Antibiotic Use and Resistance | 2021-2025 | 538 | US 125 | 90.29 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 461 | US 293 | 88.89 |
| Opioid Use Disorder Treatment | 2021-2025 | 483 | US 353 | 90.60 |
| COVID-19 Impact on Reproduction | 2021-2025 | 859 | US 286 | 82.15 |
| Maternal and fetal healthcare | 2021-2025 | 659 | US 235 | 84.50 |
| Viral Infections and Immunology Research | 2021-2025 | 972 | US 246 | 81.74 |
| Bacillus and Francisella bacterial research | 2021-2025 | 392 | US 96 | 77.91 |
| Child and Adolescent Health | 2021-2025 | 548 | US 275 | 77.48 |
| Biomedical Ethics and Regulation | 2021-2025 | 319 | US 130 | 75.88 |
| Poisoning and overdose treatments | 2021-2025 | 293 | US 148 | 75.90 |
| Pharmaceutical Economics and Policy | 2021-2025 | 752 | US 247 | 74.11 |
| Hepatitis Viruses Studies and Epidemiology | 2021-2025 | 923 | US 162 | 63.44 |
| Public Health Policies and Education | 2021-2025 | 520 | US 316 | 56.85 |
